130 related articles for article (PubMed ID: 33824762)
1. The Effect of Chronic and Inhospital Exposure to Renin-Angiotensin System Inhibitors on the Outcome and Inflammatory State of Coronavirus Disease 2019 Adult Inpatients.
Gaspar P; Parreira I; Antunes Meireles P; Bessa F; Dias Silva V; Abrantes AM; Pais de Lacerda A; Mota C
Int J Hypertens; 2021; 2021():5517441. PubMed ID: 33824762
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry.
Núñez-Gil IJ; Olier I; Feltes G; Viana-Llamas MC; Maroun-Eid C; Romero R; Fernández-Rozas I; Uribarri A; Becerra-Muñoz VM; Alfonso-Rodriguez E; García-Aguado M; Elola J; Castro-Mejía A; Pepe M; Garcia-Prieto JF; Gonzalez A; Ugo F; Cerrato E; Bondia E; Raposeiras-Roubin S; Mendez JLJ; Espejo C; López-Masjuan Á; Marin F; López-Pais J; Abumayyaleh M; Corbi-Pascual M; Liebetrau C; Ramakrishna H; Estrada V; Macaya C; Fernandez-Ortiz A;
Am Heart J; 2021 Jul; 237():104-115. PubMed ID: 33845032
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of COVID-19 Hospitalized Patients Previously Treated with Renin-Angiotensin System Inhibitors.
Cordeanu EM; Jambert L; Severac F; Lambach H; Tousch J; Heitz M; Mirea C; Hamadé A; Younes W; Frantz AS; Merdji H; Schini-Kerth V; Bilbault P; Meziani F; Ohlmann P; Andres E; Stephan D
J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33126565
[TBL] [Abstract][Full Text] [Related]
4. Renin-Angiotensin-System Inhibitors Are Associated With Lower In-hospital Mortality in COVID-19 Patients Aged 80 and Older.
Spannella F; Giulietti F; Di Pentima C; Allevi M; Bordoni V; Filipponi A; Falzetti S; Garbuglia C; Scorcella S; Giordano P; Sarzani R
Front Cardiovasc Med; 2022; 9():916509. PubMed ID: 35783862
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic.
De Luca G; Nardin M; Algowhary M; Uguz B; Oliveira DC; Ganyukov V; Zimbakov Z; Cercek M; Jensen LO; Loh PH; Calmac L; Roura Ferrer G; Quadros A; Milewski M; Scotto di Uccio F; von Birgelen C; Versaci F; Ten Berg J; Casella G; Lung AWS; Kala P; Díez Gil JL; Carrillo X; Dirksen M; Becerra-Munoz VM; Lee MK; Juzar DA; de Moura Joaquim R; Paladino R; Milicic D; Davlouros P; Bakraceski N; Zilio F; Donazzan L; Kraaijeveld A; Galasso G; Lux A; Marinucci L; Guiducci V; Menichelli M; Scoccia A; Yamac AH; Mert KU; Flores Rios X; Kovarnik T; Kidawa M; Moreu J; Flavien V; Fabris E; Martínez-Luengas IL; Boccalatte M; Bosa Ojeda F; Arellano-Serrano C; Caiazzo G; Cirrincione G; Kao HL; Sanchis Forés J; Vignali L; Pereira H; Manzo S; Ordoñez S; Arat Özkan A; Scheller B; Lehtola H; Teles R; Mantis C; Antti Y; Brum Silveira JA; Zoni R; Bessonov I; Savonitto S; Kochiadakis G; Alexopulos D; Uribe CE; Kanakakis J; Faurie B; Gabrielli G; Gutierrez Barrios A; Bachini JP; Rocha A; Tam FC; Rodriguez A; Lukito AA; Saint-Joy V; Pessah G; Tuccillo A; Cortese G; Parodi G; Bouraghda MA; Kedhi E; Lamelas P; Suryapranata H; Verdoia M
Diabet Epidemiol Manag; 2021; 4():100022. PubMed ID: 35072135
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D levels condition the outcome benefits of renin-angiotensin system inhibitors (RASI) among patients undergoing percutaneous coronary intervention.
Verdoia M; Nardin M; Rolla R; Negro F; Gioscia R; Saghir Afifeh AM; Viglione F; Suryapranata H; Marcolongo M; De Luca G;
Pharmacol Res; 2020 Oct; 160():105158. PubMed ID: 32841717
[TBL] [Abstract][Full Text] [Related]
7. The effects of renin-angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective, single-center trial.
Cui H; Wu F; Fan Z; Cheng X; Cheng J; Fan M
Med Clin (Barc); 2020 Oct; 155(7):295-298. PubMed ID: 32747012
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of Combined Renin-Angiotensin System Inhibitors and Diuretic Treatment In Patients Hospitalized with COVID-19.
Palazzuoli A; Tecson KM; Vicenzi M; D'Ascenzo F; De Ferrari GM; Monticone S; Secco GG; Tavazzi G; Forleo G; Severino P; Fedele F; De Rosa F; McCullough PA
Am J Cardiol; 2022 Mar; 167():133-138. PubMed ID: 35027137
[TBL] [Abstract][Full Text] [Related]
9. The effects of renin-angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective, single-center trial.
Cui H; Wu F; Fan Z; Cheng X; Cheng J; Fan M
Med Clin (Engl Ed); 2020 Oct; 155(7):295-298. PubMed ID: 33043142
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.
El Aidaoui K; Haoudar A; Khalis M; Kantri A; Ziati J; El Ghanmi A; Bennis G; El Yamani K; Dini N; El Kettani C
Cureus; 2020 Sep; 12(9):e10716. PubMed ID: 33033687
[TBL] [Abstract][Full Text] [Related]
11. Stopping versus continuing renin-angiotensin-system inhibitors after acute kidney injury and adverse clinical outcomes: an observational study from routine care data.
Janse RJ; Fu EL; Clase CM; Tomlinson L; Lindholm B; van Diepen M; Dekker FW; Carrero JJ
Clin Kidney J; 2022 Jun; 15(6):1109-1119. PubMed ID: 35664269
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system inhibitors prescriptions in Chinese hospitalized chronic kidney disease patients.
Zhang C; Duan ZY; Nie SS; Zhang Z; Guo XR; Zhang CY; Dong J; Cai GY
World J Clin Cases; 2024 Jun; 12(17):3061-3075. PubMed ID: 38898860
[TBL] [Abstract][Full Text] [Related]
13. Association between early worsening of kidney function and poor outcomes in patients treated with renin angiotensin system inhibitors: A meta-analysis.
Yuan S; Liu Y; He W; Jin J; Liu L; He Q
Nephrology (Carlton); 2021 Oct; 26(10):772-781. PubMed ID: 34165226
[TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
[TBL] [Abstract][Full Text] [Related]
15. Impact of renin angiotensin system inhibitors on homocysteine levels and platelets reactivity in patients on dual antiplatelet therapy.
Nardin M; Verdoia M; Gioscia R; Negro F; De Luca G
Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1276-1285. PubMed ID: 33549433
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
17. Association between renin-angiotensin system inhibitors and COVID-19 complications.
Liabeuf S; Moragny J; Bennis Y; Batteux B; Brochot E; Schmit JL; Lanoix JP; Andrejak C; Ganry O; Slama M; Maizel J; Mahjoub Y; Masmoudi K; Gras-Champel V
Eur Heart J Cardiovasc Pharmacother; 2021 Sep; 7(5):426-434. PubMed ID: 32531040
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19.
Deng F; Zhang L; Lyu L; Lu Z; Gao D; Ma X; Guo Y; Wang R; Gong S; Jiang W
Med Clin (Engl Ed); 2021 Apr; 156(7):324-331. PubMed ID: 33824908
[TBL] [Abstract][Full Text] [Related]
19. Do renin-angiotensin system inhibitors reduce risk for hepatocellular carcinoma?: A nationwide nested case-control study.
Kim KM; Roh JH; Lee S; Yoon JH
Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101510. PubMed ID: 33272886
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study.
Moreno G; Carbonell R; Martin-Loeches I; Solé-Violán J; Correig I Fraga E; Gómez J; Ruiz-Botella M; Trefler S; Bodí M; Murcia Paya J; Díaz E; Vidal-Cortes P; Papiol E; Albaya Moreno A; Sancho Chinesta S; Socias Crespi L; Lorente MDC; Loza Vázquez A; Vara Arlanzon R; Recio MT; Ballesteros JC; Ferrer R; Fernandez Rey E; Restrepo MI; Estella Á; Margarit Ribas A; Guasch N; Reyes LF; Marín-Corral J; Rodríguez A;
Ann Intensive Care; 2021 Nov; 11(1):159. PubMed ID: 34825976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
